High-density microcarrier cell cultures for influenza virus production

Biotechnology Progress

Volumn 27, Issue 1, 2011, Pages 241-250

  Bock, A ^a   Schulze Horsel, J ^a   Schwarzer, J ^a   Rapp, E ^a   Genzel, Y ^a   Reichl, U ^a,b  

^a MAX PLANCK INSTITUTE FOR DYNAMICS OF COMPLEX TECHNICAL SYSTEMS   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

High density cell culture; Influenza; MDCK; Microcarrier; Vaccine

Indexed keywords

CELL CONCENTRATIONS; CELL DENSITY; FED BATCHES; FEED-RATES; HIGH-DENSITY; HIGH-DENSITY CELL CULTURE; HIGH-DENSITY CULTURES; INFLUENZA; INFLUENZA VIRUS; MADIN-DARBY CANINE KIDNEY CELLS; MDCK; MICROCARRIER CULTURE; MICROCARRIERS; VIRUS PROPAGATION; VIRUS STRAINS;

VIRUSES;

CELL CULTURE;

ANIMAL; ARTICLE; BIOREACTOR; CELL LINE; CULTURE MEDIUM; DOG; INFLUENZA VIRUS A; PHYSIOLOGY; VIRUS REPLICATION;

ANIMALS; BIOREACTORS; CELL LINE; CULTURE MEDIA; DOGS; INFLUENZA A VIRUS; VIRUS REPLICATION;

ORTHOMYXOVIRIDAE;

EID: 79851484877     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.539     Document Type: Article

References (44)

1. Bleckwenn NA, Golding H, Bentley WE, Shiloach J. Production of recombinant proteins by vaccinia virus in a microcarrier based mammalian cell perfusion bioreactor. Biotechnol. Bioeng. 2005; 90: 663-674.
2. Bock A, Möhler L, Sann H, Schulze-Horsel J, Genzel Y, Reichl U. Growth behaviour of number distributed adherent MDCK cells in microcarrier cultures. Biotechnol. Progr. 2009; 29: 1717-1731.
3. Burleson F, Wiedbrauk C. 1992. Virology. A Laboratory Manual. San Diego: Academic Press.
4. Butler M. Optimisation of the cellular metabolism of glycosylation for recombinant proteins produced by mammalian cell systems. Cytotechnology. 2006; 50: 57-76.
5. Butler M, Imamura T, Thomas J, Thilly WG. High yields from microcarrier cultures by medium perfusion. J. Cell. Sci. 1983; 61: 351-363.
6. Castilho L, Medronho R. Cell retention devices for suspended-cell perfusion cultures. In: Scheper T, editor. Advances in Biochemical Engineering/Biotechnology. Berlin, Heidelberg: Springer-Verlag; 2002: 129-169.
7. Chico E, Jager V. Perfusion culture of baculovirus-infected BTI-Tn-5B1-4 insect cells: a method to restore cell-specific beta-trace glycoprotein productivity at high cell density. Biotechnol. Bioeng. 2000; 70: 574-586.
8. Choppin PW. Plaque formation by influenza A2 virus in monkey kidney cells. Virology. 1962; 18: 332-334.
9. Dong H, Tang YJ, Ohashi R, Hamel JFP. A perfusion culture system using a stirred ceramic membrane reactor for hyperproduction of IgG(2a) monoclonal antibody by hybridoma cells. Biotechnol. Progr. 2005; 21: 140-147.
10. Dowd JE, Jubb A, Kwok KE, Piret JM. Optimization and control of perfusion cultures using a viable cell probe and cell specific perfusion rates. Cytotechnology. 2003; 42: 35-45.
11. Genzel Y, Behrendt I, Konig S, Sann H, Reichl U. Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture. Vaccine. 2004; 22: 2202-2208.
12. Genzel Y, Olmer RM, Schafer B, Reichl U. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media. Vaccine. 2006; 24: 6074-6087.
13. Genzel Y, Reichl U. Continuous cell lines as a production system for influenza vaccines. Exp Rev Vaccines. 2009; 8: 1681-1692.
14. Genzel Y, Ritter JB, Konig S, Alt R, Reichl U. Substitution of glutamine by pyruvate to reduce ammonia formation and growth inhibition of mammalian cells. Biotechnol. Progr. 2005; 21: 58-69.
15. Green IJ. Serial propagation of influenza B (Lee) virus in a transmissible line of canine kidney cells. Science. 1962; 138: 42-43.
16. Henry O, Dormond E, Perrier M, Kamen A. Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures. Biotechnol. Bioeng. 2004; 86: 765-774.
17. Himmelfarb P, Thayer PS, Martin HE. Spin filter culture-propagation of mammalian cells in suspension. Science 1969; 164(3879): 555-557.
18. Ishida M, Haga R, Nishimura N, Matuzaki H, Nakano R. High cell-density suspension-culture of mammalian anchorage independent cells-oxygen-transfer by gas sparging and defoaming with a hydrophobic net. Cytotechnology. 1990; 4: 215-225.
19. Kalbfuss B, Wolff M, Morenweiser R, Reichl U. Purification of cell culture-derived human influenza a virus by size-exclusion and anion-exchange chromatography. Biotechnol. Bioeng. 2007; 96: 932-944.
20. Kallel H, Jouini A, Majoul S, Rourou S. Evaluation of various serum and animal protein free media for the production of a veterinary rabies vaccine in BHK-21 cells. J. Biotechnol. 2002; 95: 195-204.
21. Lee GM, Choi JH, Jun SC, Palsson BO. Temperature significantly affects retroviral vector production and deactivation rates, and thereby determines retroviral titers. Bioprocess Eng. 1998; 19: 343-349.
22. Leiderman E, Mogabgab WJ. Antigenicity of influenza vaccine from bovine cell cultures. Appl. Microbiol. 1969; 18: 596-600.
23. Lindsay DA, Betenbaugh MJ. Quantification of cell-culture factors affecting recombinant protein yields in baculovirus-infected insect cells. Biotechnol. Bioeng. 1992; 39: 614-618.
24. Lloyd DR, Leelavatcharamas V, Emery AN, Al-Rubeai M. The role of the cell cycle in determining gene expression and productivity in CHO cells. Cytotechnology. 1999; 30: 49-57.
25. Lohr V, Rath A, Genzel Y, Jordan I, Sandig V, Reichl U. New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation. Vaccine. 2009; 27: 4975-4982.
26. Maranga L, Brazao TF, Carrondo MJT. Virus-like particle production at low multiplicities of infection with the baculovirus insect cell system. Biotechnol Bioeng. 2003; 84: 245-253.
27. Merten OW, Manuguerra J-C, Hannoun C, van der Werf S. Production of influenza virus in serum-free mammalian cell cultures. In: Brown F, Robertson JS, Schild GC, Wood JM, editors. Inactivated influenza vaccines prepared in cell culture. Basel, Karger: Dev. Biol. Stand.; 1999; 98: 23-37.
28. Morgan M, Faik P. In: Morgan M, editor. The Utilization of Carbohydrates by Animal Cells. New York: Plenum Press; 1986.
29. Perrin P, Madhusudana S, Gontierjallet C, Petres S, Tordo N, Merten OW. An experimental rabies vaccine produced with a new BHK-21 suspension cell-culture process-use of serum-free medium and perfusion-reactor system. Vaccine. 1995; 13: 1244-1250.
30. Pohlscheidt M, Bodeker B, Langer U, Apeler H, Horlein HD, Rubsamen-Waigmann H, Reichl U, Henzler HJ. Interpretation data for bioreactors for the increase of scale of a microcarrier-based virus production process. Chemie Ingenieur Technik. 2008; 80: 821-830.
31. Quesney S, Marc A, Gerdil C, Gimenez C, Marvel J, Richard Y, Meignier B. Kinetics and metabolic specificities of Vero cells in bioreactor cultures with serum-free medium. Cytotechnology. 2003; 42: 1-11.
32. Schulze-Horsel J, Genzel Y, Reichl U. Flow cytometric monitoring of influenza A virus infection in MDCK cells during vaccine production. BMC Biotechnol. 2008; 8: 45.
33. Schulze-Horsel J, Schulze M, Agalaridis G, Genzel Y, Reichl U. Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production-flow cytometry and mathematical modeling. Vaccine. 2009; 27: 2712-2722.
34. Schulze-Horsel J, Schulze M, Genzel Y, Reichl U. In: Noll T, editor. Cells and Culture. Dresden, Germany: Springer; 2007.
35. Schwabe JO, Portner R, Markl H. Improving an on-line feeding strategy for fed-batch cultures of hybridoma cells by dialysis and 'Nutrient-Split'-feeding. Bioprocess Eng. 1999; 20: 475-484.
36. Schwarzer J, Rapp E, Hennig R, Genzel Y, Jordan I, Sandig V, Reichl U. Glycan analysis in cell culture-based influenza vaccine production: Influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin. Vaccine. 2009; 27: 4325-4336.
37. Schwarzer J, Rapp E, Reichl U. N-glycan analysis by CGE-LIF: profiling influenza A virus hemagglutinin N-glycosylation during vaccine production. Electrophoresis. 2008; 29: 4203-4214.
38. Shirgaonkar IZ, Lanthier S, Kamen A. Acoustic cell filter: a proven cell retention technology for perfusion of animal cell cultures. Biotechnol. Adv. 2004; 22: 433-444.
39. Tree JA, Richardson C, Fooks AR, Clegg JC, Looby D. Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains. Vaccine. 2001; 19: 3444-3450.
40. Voisard D, Meuwly F, Ruffieux PA, Baer G, Kadouri A. Potential of cell retention techniques for large-scale high-density perfusion culture of suspended mammalian cells. Biotechnol. Bioeng. 2003; 82: 751-765.
41. Wong KTK, Peter CH, Greenfield PF, Reid S, Nielsen LK. Low multiplicity infection of insect cells with a recombinant baculovirus: the cell yield concept. Biotechnol. Bioeng. 1996; 49: 659-666.
42. Wood HA, Johnston LB, Burand JP. Inhibition of Autographa californica nuclear polyhedrosis virus replication in high-density Trichoplusia ni cell cultures. Virology 1982; 119: 245-254.
43. Xie LZ, Wang DIC. Applications of improved stoichiometric model in medium design and fed-batch cultivation of animal-cells in bioreactor. Cytotechnology. 1994; 15: 17-29.
44. Zhang CH, Ferreira TB, Cruz PE, Alves PM, Haury M, Carrondo MJT. The importance of 293 cell cycle phase on adenovirus vector production. Enzyme Microbial Technol. 2006; 39: 1328-1332.